Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease

88Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.
Get full text

Abstract

To evaluate the possible involvement of vascular endothelial growth factor (VEGF) in the pathogenesis of Castleman's disease, we studied VEGF levels in sera and supernatants of cultured lymph nodes from two patients with the plasma cell type of Castleman's disease, and analysed the expression of VEGF immunohistochemically in the lymph nodes. Clinically, one patient was classified as the localized type and the other as the multicentric type. Histologically, mature plasma cells and hyalinized vessels were prominent in the interfollicular region. The VEGF levels of the sera and the supernatants of cultured lymph nodes of both patients were higher than those of normal controls. VEGF was strongly expressed in plasma cells in the interfollicular region of the lymph nodes of both patients, but rarely in normal lymph nodes. Our results suggest that VEGF may be involved in the marked vascular proliferation in the interfollicular region of the lymph nodes of he plasma cell type of Castleman's disease.

Cite

CITATION STYLE

APA

Nishi, J. I., Arimura, K., Utsunomiya, A., Yonezawa, S., Kawakami, K., Maeno, N., … Maruyama, I. (1999). Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman’s disease. British Journal of Haematology, 104(3), 482–485. https://doi.org/10.1046/j.1365-2141.1999.01208.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free